AMERICAN INTERNATIONAL GROUP, INC. - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 100 filers reported holding APELLIS PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.00 and the average weighting 0.3%.

Quarter-by-quarter ownership
AMERICAN INTERNATIONAL GROUP, INC. ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2024$99,044
-3.2%
1,685
-1.5%
0.00%
Q4 2023$102,361
+55.3%
1,710
-1.3%
0.00%
Q3 2023$65,923
-61.0%
1,733
-6.5%
0.00%
-100.0%
Q2 2023$168,899
-94.3%
1,854
-95.9%
0.00%
-95.0%
Q1 2023$2,985,416
+30.1%
45,261
+2.0%
0.02%
+25.0%
Q4 2022$2,293,907
-24.6%
44,361
-0.4%
0.02%
-27.3%
Q3 2022$3,041,000
+58.1%
44,522
+4.6%
0.02%
+69.2%
Q2 2022$1,924,000
-2.4%
42,558
+9.6%
0.01%
+18.2%
Q1 2022$1,972,000
+9.8%
38,816
+2.2%
0.01%
+22.2%
Q4 2021$1,796,000
+53.2%
37,988
+6.9%
0.01%
+50.0%
Q3 2021$1,172,000
-49.0%
35,549
-2.3%
0.01%
-25.0%
Q2 2021$2,300,000
+53.1%
36,394
+4.0%
0.01%
+60.0%
Q1 2021$1,502,000
-24.8%
35,001
+0.3%
0.01%
-28.6%
Q4 2020$1,997,000
+84.4%
34,909
-2.8%
0.01%
+40.0%
Q3 2020$1,083,000
-9.8%
35,911
-2.2%
0.01%
-16.7%
Q2 2020$1,200,000
+32.2%
36,727
+8.4%
0.01%
+20.0%
Q1 2020$908,000
-3.0%
33,877
+10.8%
0.01%
+25.0%
Q4 2019$936,000
+27.3%
30,580
+0.2%
0.00%
+33.3%
Q3 2019$735,000
-5.6%
30,521
-0.7%
0.00%0.0%
Q2 2019$779,000
+73.5%
30,734
+33.5%
0.00%
+50.0%
Q1 2019$449,000
+43.0%
23,030
-3.1%
0.00%
+100.0%
Q4 2018$314,000
-26.3%
23,777
-0.8%
0.00%0.0%
Q3 2018$426,000
-17.8%
23,960
+1.8%
0.00%
-50.0%
Q2 2018$518,000
+232.1%
23,528
+232.7%
0.00%
+100.0%
Q1 2018$156,000
-1.3%
7,071
-3.0%
0.00%0.0%
Q4 2017$158,0007,2920.00%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
AJU IB Investment Co., Ltd. 624,962$20,599,00013.29%
Octagon Capital Advisors LP 1,595,911$52,601,00012.95%
Logos Global Management LP 1,450,000$47,792,0003.45%
Avoro Capital Advisors LLC 5,000,000$164,800,0002.59%
Ghost Tree Capital, LLC 200,000$6,592,0001.93%
Integral Health Asset Management, LLC 190,000$6,262,0001.80%
GREAT POINT PARTNERS LLC 200,000$6,592,0001.54%
Aufman Associates Inc 53,642$1,768,0001.45%
Ghost Tree Capital, LLC 150,000$4,944,0001.45%
Altium Capital Management LP 166,700$5,494,0001.44%
View complete list of APELLIS PHARMACEUTICALS INC shareholders